Endometrial Biopsy
9
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
1% Lidocaine Paracervical Block for Endometrial Biopsy
Methoxyflurane for IUD Insertion and Endometrial Biopsy
The Effect of Virtual Reality on Women Undergoing Endometrial Biopsy
The Effect of Virtual Reality on Anxiety and Pain During Endometrial Biopsy
Therapeutic Endometrial Biopsy
Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy
COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy
Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy
Oral Misoprostol Before Endometrial Biopsy